AstraZeneca to acquire Alexion for $39B
December 14, 2020
WILMINGTON – The pharmaceutical giant AstraZeneca announced Saturday that it has reached an agreement to acquire rare disease specialist Alexion Pharmaceuticals Inc. for $39 billion, the largest industry deal this […]
chat_bubble0 Comment
visibility969 Views
Premier Digital Partners
© 2023 Delaware Business Times
